Back to search
FDAFDA · Food and drugs·Recall number D-0397-2026

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

Published March 11, 2026 · Recall initiated: December 15, 2025

Summary

FDA records drug Class I recall D-0397-2026, published March 11, 2026 and initiated December 15, 2025. Recalling firm: StuffbyNainax; Status: Ongoing; Reported quantity: 4; Lot: All codes; Exp 12/31/2029. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
StuffbyNainax
Distributor
Product was distributed to 4 customers in the US.
Lot
All codes; Exp 12/31/2029
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7 recalled?

Yes. FDA published recall D-0397-2026 on March 11, 2026. Reported hazard: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

What should I do if I have this product?

Voluntary: Firm initiated · Press Release